These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21254338)

  • 1. Predicting cardiovascular complications after liver transplantation: 007 to the rescue?
    Liu H; Lee SS
    Liver Transpl; 2011 Jan; 17(1):7-9. PubMed ID: 21254338
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels.
    Coss E; Watt KD; Pedersen R; Dierkhising R; Heimbach JK; Charlton MR
    Liver Transpl; 2011 Jan; 17(1):23-31. PubMed ID: 21254341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Troponin I and cardiovascular events in transplant patients.
    Afsar B; Elsure R
    Transplantation; 2010 Aug; 90(3):339; author reply 339-40. PubMed ID: 20683433
    [No Abstract]   [Full Text] [Related]  

  • 4. A preliminary report on the prognostic significance of preoperative brain natriuretic peptide and postoperative cardiac troponin in patients undergoing major vascular surgery.
    Bolliger D; Seeberger MD; Lurati Buse GA; Christen P; Rupinski B; Gürke L; Filipovic M
    Anesth Analg; 2009 Apr; 108(4):1069-75. PubMed ID: 19299763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple biomarker panels for cardiovascular risk assessment.
    de Lemos JA; Lloyd-Jones DM
    N Engl J Med; 2008 May; 358(20):2172-4. PubMed ID: 18480211
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.
    Zethelius B; Berglund L; Sundström J; Ingelsson E; Basu S; Larsson A; Venge P; Arnlöv J
    N Engl J Med; 2008 May; 358(20):2107-16. PubMed ID: 18480203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple biomarkers for predicting cardiovascular events: lessons learned.
    Wang TJ
    J Am Coll Cardiol; 2010 May; 55(19):2092-5. PubMed ID: 20447531
    [No Abstract]   [Full Text] [Related]  

  • 8. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
    van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
    Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troponin I and cardiovascular risk stratification in patients with testicular cancer.
    Cardinale D; Lamantia G; Cipolla CM
    J Clin Oncol; 2006 Jul; 24(21):3508; author reply 3508-9. PubMed ID: 16849772
    [No Abstract]   [Full Text] [Related]  

  • 10. CRP has little incremental value over traditional cardiovascular risk factors in risk stratification.
    Farkouh ME; Bansilal S; Mathew V
    Nat Clin Pract Cardiovasc Med; 2007 Jun; 4(6):290-1. PubMed ID: 17522718
    [No Abstract]   [Full Text] [Related]  

  • 11. Should we measure CRP levels to assess cardiovascular risk?
    Hadley RD; Graber MA
    JAAPA; 2003 Jan; 16(1):17-9. PubMed ID: 12635434
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel cardiac markers.
    Alder R
    Adv Nurse Pract; 2009 Jun; 17(6):24-7; quiz 28. PubMed ID: 20000180
    [No Abstract]   [Full Text] [Related]  

  • 13. Is early assessment of cardiac troponin I a valuable predictor of mortality after cardiac surgery?
    Tzimas P; Baikoussis NG; Kalantzi K; Papadopoulos G
    Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):416-7. PubMed ID: 20185847
    [No Abstract]   [Full Text] [Related]  

  • 14. Is high-sensitivity C-reactive protein associated with subclinical peripheral atherosclerosis?
    Paraskevas KI; Bessias N; Papas TT; Andrikopoulos V; Mikhailidis DP
    Angiology; 2009; 60(1):8-11. PubMed ID: 19190029
    [No Abstract]   [Full Text] [Related]  

  • 15. C-reactive protein in cardiovascular risk prediction. Zooming in and zooming out.
    Maseri A
    Ital Heart J; 2001 Mar; 2(3):155-6. PubMed ID: 11305525
    [No Abstract]   [Full Text] [Related]  

  • 16. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    Hamer M; Chida Y; Stamatakis E
    Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein predicts future arterial and cardiovascular events in patients with symptomatic peripheral arterial disease.
    Hogh AL; Joensen J; Lindholt JS; Jacobsen MR; Ostergaard L
    Vasc Endovascular Surg; 2008; 42(4):341-7. PubMed ID: 18458051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diseases from every organ system can raise cardiac troponin concentration.
    Goran KP
    Resuscitation; 2010 Jan; 81(1):128. PubMed ID: 19850396
    [No Abstract]   [Full Text] [Related]  

  • 19. Noninvasive assessment of cardiovascular risk: from Framingham to the future.
    Vogel RA; Benitez RM
    Rev Cardiovasc Med; 2000; 1(1):34-42. PubMed ID: 12457150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C- Reactive protein, cardiac troponin T and low albumin are predictors of mortality in hemodialysis patients.
    Bagheri N; Taziki O; Falaknazi K
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):789-93. PubMed ID: 19736474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.